Delphi Genetics more than triples its production capacity and receives GMP certification. New Plasmid DNA production capacities now immediately available.

March 25th 2020


Delphi Genetics announces today that it has received the coveted GMP certificate, issued by the AFMPS, covering its brand new state-of-the-art GMP manufacturing suites. « The approval of these additional three suites allows Delphi Genetics to very significantly enhance its production capacities for plasmid DNA manufacturing and further assist the development of gene therapy candidates and DNA-based therapies », commented François Blondel, Chairman of the board of Directors and CEO. Please discover the press release here.